Covalon Reports Highest Revenue Quarter of Fiscal Year 2025, Delivers Third Consecutive Year of Revenue Growth
Executive Summary
- Covalon Technologies reported FY 2025 revenue of $32.8 M (+5% YoY) and net income of $2.06 M, delivering its first special dividend of $0.15 CAD per share.
- Q4 2025 revenue slipped 2% to $8.69 M; gross margin fell to 51% (down from 60%) due to product mix changes and inventory write‑offs.
- The company secured a new U.S. strategic partner with a >$1 M purchase order for FY 2026 Q2 and completed an ISO 13485 surveillance audit with zero non‑conformances.
Key Details
- Financial Highlights – Q4 2025 (3 months ended Sep 30, 2025)
- Revenue: $8,691,972 (‑2% YoY)
- Gross profit: $4,445,397; gross margin: 51.2% (down from 60.2%)
- Operating expenses: $4,199,551 (‑10% YoY)
- Net income: $358,337; diluted EPS: $0.01
-
Adjusted EBITDA: $695,603
-
Financial Highlights – FY 2025 (12 months ended Sep 30, 2025)
- Revenue: $32,816,347 (+5% YoY)
- Gross profit: $17,471,864; gross margin: 53.2% (down from 60.7%)
- Operating expenses: $15,708,192 (‑6% YoY)
- Net income: $2,058,089; diluted EPS: $0.07
-
Adjusted EBITDA: $3,709,818
-
Dividend – First special dividend of $0.15 CAD per share paid on Nov 4, 2025 (total payout $4.1 M). Cash balance post‑dividend: $17.0 M CAD.
-
Strategic Partner & Order – New U.S. advanced wound care partner placed a purchase order >$1 M for delivery in FY 2026 Q2.
-
Operational Achievements
- ISO 13485 surveillance audit completed with zero non‑conformances.
- VALGuard® line guard clinical study published in Journal of the Association for Vascular Access, showing significant CLABSI reduction.
-
U.S. vascular access & surgical consumables channel recorded >50% YoY revenue growth; International channel nearly doubled Q4 revenues and grew >40% FY 2025.
-
Leadership Update – Board appointed Katie Martinovich as CFO, removing “Interim” designation (effective Dec 10, 2025).
-
Conference Call – Earnings call scheduled for Thu Dec 11, 2025 at 8:30 am ET; webcast link provided.
Notable Quotes
“We delivered our highest revenue quarter of the year in Q4 and are proud to pay Covalon’s first ever special dividend… I’m extremely proud of the advancements we have made and laser‑focused on actions to accelerate growth and increase shareholder value in FY 26 and beyond.” – Brent Ashton, CEO
Materiality Assessment: Material – Positive (full‑year results, dividend declaration, strategic partnership, and operational milestones constitute a material update for investors).